It is very interesting that in the Bio-Med report the completion of Agenda is stated as a matter of fact and not opinion: "Their phase III AGENDA trial for Genasense has been completed, and results are expected in the fourth quarter, which could be any day- two weeks from now going forward."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.